NYSE$ENOV

Enovis Corp · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

Enovis' Q3 2023 results reflected sales growth, margin expansion, and progress in the Reconstructive segment, with an increased full-year outlook.

Enovis reported a 9% increase in third-quarter sales to $418 million, driven by strong growth in the Reconstructive segment and stability in the Prevention and Recovery segment. The company's adjusted EBITDA margin improved by 80 basis points, and adjusted earnings per diluted share were $0.56. Enovis raised its full-year outlook for organic revenue growth and adjusted EBITDA.

  • Third quarter sales grew by 9%, with 6.2% organic sales per day growth.
  • Reconstructive segment sales increased by 16%, with 10% organic growth.
  • Prevention and Recovery segment sales grew by 5%, with 4% organic growth.
  • Adjusted EBITDA margin improved by 80 basis points year over year.

Headline financials

Total Revenue

$418M

Previous: $384M+8.8%
EPS (adj)

$0.56

Previous: $0.59-5.1%
Adjusted EBITDA Margin

15.7%

No prior period
Capital Expenditures

-$94.3M

Previous: -$68.7M-37.3%
Free Cash Flow

-$97.2M

Previous: -$135M+28.2%
Net Income

-$2.88M

Previous: -$66.6M+95.7%
Operating Income

-$20.5M

Previous: -$17.9M-14.4%
Gross Profit

$243M

Previous: $216M+12.6%
Cash & Equivalents

$32.1M

Previous: $55M-41.5%
Total Assets

$4.4B

Previous: $4.44B-1.0%
R&D Expense

$19.9M

No prior period
Stock-Based Comp

$8.78M

Previous: $8.01M+9.6%

Revenue & EPS history

Enovis · Revenue · Quarterly

$418M

Q3 2023+8.8%vs Q3 2022
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Revenue by segment

Enovis · $131M total across 1 segment · Q2 2022

  • Reconstructive
    $131M

Forward guidance

Enovis updated its financial expectations for 2023, projecting organic revenue growth of 7.4-7.6% and adjusted EBITDA of $264-$270 million. The Company also updated its full-year adjusted earnings per diluted share guidance to $2.30-$2.40.

Tailwinds

  • Revenue is expected to organically grow 7.4-7.6% from the prior year versus previous expectations of 7-7.5% growth
  • Adjusted EBITDA is forecasted to be $264-$270 million as compared with the previous outlook of $262-$270 million.
  • Full-year adjusted earnings per diluted share guidance to $2.30-$2.40 from $2.22-$2.36.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

+1.6%

Avg return

Earnings day

+1.3%

Avg return

5 days after

+0.1%

Avg return

30 days after

52%

33 / 64 earnings

Positive

+21.3%

Q3 2011

Best reaction

-18.7%

Q1 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+9.7%+4.0%-4.5%
Q4 2025+13.8%+13.3%-2.2%
Q3 2025-9.7%+0.1%-14.2%
Q1 2025-2.9%+9.1%-7.2%
Q4 2024-4.9%-10.1%-10.3%
Q3 2024+10.6%+9.3%+10.0%
Q2 2024+4.0%+1.0%+3.5%
Q1 2024-7.5%-5.7%-9.3%
Q4 2023+4.3%+2.0%-0.1%
Q3 2023+4.0%+3.2%+8.8%
Q2 2023-5.6%-8.1%-10.0%
Q1 2023-1.8%-3.7%-3.9%
Q4 2022-9.6%-6.4%-18.9%
Q3 2022-3.4%+7.4%+15.9%
Q2 2022-3.7%-4.4%-17.5%
Q1 2022+5.7%+5.9%+7.4%
Q4 2021+0.9%+2.8%-3.7%
Q3 2021+0.4%-1.4%-14.9%
Q2 2021+3.6%+2.1%+8.5%
Q1 2021-1.1%-5.9%-3.2%
Q4 2020+13.7%+17.2%+16.8%
Q3 2020-4.1%+3.0%+30.8%
Q2 2020+6.8%+13.0%+8.1%
Q1 2020+14.6%+6.6%+33.4%
Q4 2019+2.8%-5.1%-55.3%
Q3 2019+9.6%+11.5%+6.0%
Q2 2019+7.9%+5.3%+15.1%
Q1 2019-5.5%-6.5%-4.7%
Q4 2018+5.3%+6.8%+15.0%
Q3 2018-0.3%+0.8%-12.5%
Q2 2018+5.5%+0.8%+12.9%
Q1 2018+2.2%+5.3%+1.1%
Q4 2017-8.5%-14.2%-11.2%
Q3 2017-12.7%-13.7%-14.0%
Q2 2017+1.1%+0.9%-4.3%
Q1 2017+1.9%+2.4%+7.4%
Q4 2016+2.2%-0.5%-5.0%
Q3 2016+7.8%+5.4%+26.9%
Q2 2016+0.0%-3.2%+3.4%
Q1 2016-18.7%
Q4 2015+18.9%
Q3 2015-6.5%
Q2 2015-5.1%
Q1 2015-0.8%
Q4 2014-0.9%
Q3 2014-5.1%
Q2 2014-6.9%
Q1 2014-3.4%
Q4 2013+7.0%
Q3 2013+0.0%
Q2 2013-0.1%
Q1 2013+4.5%
Q4 2012-5.8%
Q3 2012-2.7%
Q2 2012+5.2%
Q1 2011-5.7%
Q1 2012+1.3%
Q4 2011-1.9%
Q3 2011+21.3%
Q2 2011+16.2%
Q4 2010+16.2%
Q2 2010+16.2%
Q3 2010+1.0%
Q1 2010+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro